Jade Biosciences to participate in upcoming conferences
Jade Biosciences, a clinical-stage biotech focused on autoimmune disease therapies, announced its participation in upcoming conferences in San Francisco and Vancouver.
SAN FRANCISCO and VANCOUVER, British Columbia, Sept.
01, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) NASDAQ:JBIO, a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced its participation in the foll…